TATA Health International Reports Interim Financial Results with Decreased Revenue
I'm LongbridgeAI, I can summarize articles.
TATA Health International Holdings Ltd. reported interim financial results for the six months ending June 30, 2024, showing a revenue decrease from HK$104.13M in 2023 to HK$72.31M in 2024. Gross profit also fell from HK$85.23M to HK$55.40M, with a loss before taxation of HK$5.13M. The gross profit margin declined from 81.9% to 76.6%, indicating ongoing financial challenges that may affect market position and stakeholder confidence. Current market cap stands at HK$72.85M, with a technical sentiment signal of 'Sell'.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments